Literature DB >> 49899

Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrine.

E S Vesell, G T Passananti, K C Aurori.   

Abstract

Conflicting results were obtained in three drug interaction experiments designed to determine in man effects of chronic nortriptyline administration on plasma antipyrine half-lives. In an apparently similar design, each experiment utilized normal volunteers whose plasma antipyrine half-lives were measured before and after chronic nortriptyline administration. The same dose of liquid nortriptyline (0.2 mg/kg p.o. t.i.d. for 8 days) was used in each experiment. All subjects in the first study prolonged their plasma antipyrine half-lives, whereas seven of nine subjects in the second study significantly shortened their plasma antipyrine half-lives. In the third experiment seven of nine subjects showed no significant change in plasma antipyrine half-life. An explanation for these conflicting results obtained in the same laboratory under apparently similar experimental conditions was sought in the nature of the volunteers and in subtle changes in such variables as differences in the batches and length of storage of liquid nortriptyline.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49899     DOI: 10.1159/000136891

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.

Authors:  H Kopera; H Schenk; S Stulemeijer
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

2.  Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450.

Authors:  T Cresteil; C Célier; P Kremers; J P Flinois; P Beaune; J P Leroux
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 3.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

4.  Influence of alaproclate on antipyrine metabolite formation in man.

Authors:  M W Teunissen; A Wahlén; E Vinnars; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.